NCT00435370View on ClinicalTrials.gov

Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

179

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

February 28, 2011

Study Completion Date

August 31, 2011

Conditions
Smoking CessationSchizophrenia
Interventions
DRUG

Tropisetron

10 mg/day

DRUG

Placebo

placebo

DRUG

Risperidone

6mg/day

Trial Locations (2)

77030

Baylor College of Medicine - Michael E. DeBakey VA Medical Center, Houston

Unknown

Beijing Hui-Long Guan Hospital, Beijing

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Baylor College of Medicine

OTHER

NCT00435370 - Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in Schizophrenia | Biotech Hunter | Biotech Hunter